March 06, 2019

What To Expect From USPTO On Patent Term Post-Supernus

Matt Kamps, Dan Schwartz and Alyssa Eckerley authored an article for Law360 about what to expect from the U.S. Patent and Trademark Office (USPTO) on patent term post-supernus. 
"Though it remains to be seen when and how the USPTO will address, codify and apply Supernus, its treatment of Novartis provides some predictive value with respect to its future approach. In the interim, it may behoove patentees to identify their Supernus-eligible patents and consider whether a PTA petition is warranted."Kamps, schwartz, eckerley, law360
全文

Services and Industries

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.